|Articles|September 1, 2018
- Pharmaceutical Executive-09-01-2018
- Volume 38
- Issue 9
Pharmaceutical Executive, September 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Paul Perreault: The Global CEOabout 7 years ago
Specialty Pharma’s Move to Mainstreamabout 7 years ago
Specialty Product Launch Insightsabout 7 years ago
Beyond Big Data: Meeting the Specialty Marketing Challengeabout 7 years ago
Specialty Focus: Tackling Rare Mutation in CFabout 7 years ago
The ‘Spare-No-Expense’ Alternativeabout 7 years ago
Pharm Exec's 17th Annual Industry Auditabout 7 years ago
Specialty Supply Chain Decisionsover 7 years ago
FDA Struggles to Advance Biosimilarsover 7 years ago
Country Report: UKNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
FDA Announces Agency-Wide Deployment of Agentic AI Tools
4
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
5
